When Jill Harman went to get her COVID-19 vaccine at an Ingles Market pharmacy in rural Georgia, she mentioned to… Read more »
Updated Jan. 7: The U.S. Centers for Disease Control and Prevention gave an update during a Jan. 6 press briefing… Read more »
The FDA is considering approval of the AR101 peanut immunotherapy and will soon evaluate the Viaskin Peanut patch. But if… Read more »
The FDA has granted fast-track status to a promising vaccine intended to help celiac patients tolerate some gluten exposure, which… Read more »
Fifty percent of the celiac patients under the age of 5 were nonresponsive to the vaccine compared to 30 percent of the control group.